ID   OARSAi001-A
AC   CVCL_VN66
SY   S04
DR   BioSamples; SAMEA4760915
DR   hPSCreg; OARSAi001-A
DR   Wikidata; Q98128266
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12
ST   D21S11: 28,32.2
ST   D3S1358: 13,18
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=30099336; DOI=10.1016/j.scr.2018.07.013;
RA   Gao, Xiu-Gong
RA   Yourick, Jeffrey J.
RA   Sprando, Robert L.
RT   "Generation of nine induced pluripotent stem cell lines as an ethnic
RT   diversity panel.";
RL   Stem Cell Res. 31:193-196(2018).
//